MetaboliteDeutetrabenazine Metabolite 1 (Mixture of Diastereomers)Cat. No. P-D067-002CAS 1778697-55-4Family · Pharmaceutical analytical standards
Deutetrabenazine
A vesicular monoamine transporter 2 (VMAT2) inhibitor, used for chorea in Huntington's disease and for tardive dyskinesia. It was approved in the US in 2017, the first deuterated drug to receive FDA approval. This family brings together metabolites.
Did you know?It is the 'heavy' version of tetrabenazine: six hydrogen atoms in its two methoxy groups are replaced by deuterium, an isotope of hydrogen that slows down the drug's metabolism.
MetaboliteDeutetrabenazine Metabolite 1 (Mixture of Diastereomers)Cat. No. P-D067-002CAS 1778697-55-4
MetaboliteDeutetrabenazine Metabolite 2Cat. No. P-D067-003CAS 1688661-95-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.